Health Care Equipment & Services

Perimeter Medical Imaging AI Inc. boosts its healthcare reach with a new partnership with Intermountain Health while navigating stock volatility and a current loss‑based valuation.

Institutional trading shows mixed sentiment for Stryker Corp. while big investors like Penobscot add shares, confident in its R&D‑driven growth and global reach.

Align Technology’s stock faces a sharp valuation shift: Jefferies lifts ALGN’s target to $185, while a Brighton Jones sell‑off and a Nasdaq pullback test the company’s growth prospects.

CVS Health Corp’s latest moves—TrumpRx expansion, Aetna’s award and mixed institutional trading—show a high‑valuation play seeking growth amid PBM volatility.

Explore Aclarion Inc.’s 2026 Chairman’s shareholder letter—inside its AI‑driven MRS tech, micro‑cap status, and why the market hasn’t yet caught up.

Medios AG’s managing director buys 13,638 shares—no change in strategy, just routine remuneration. Discover what this means for the German pharma player’s market and patient‑care focus.

Explore how PACS Group’s stock and strategy are shaped by rising tech in healthcare and new digital finance trends, including Merge’s KLAS win and India’s PACS grant.

CVS Health’s new TrumpRx partnership, biosimilar swaps, and veteran‑access plan show how the pharmacy giant is reshaping drug pricing, cutting costs and boosting competition while facing regulatory scrutiny and investor pressure.

Veeva Systems boosts its life‑sciences edge as 13 of the largest biopharma firms adopt its Link Key People platform, adding AI tools and APIs that standardize engagement data for faster decision‑making and future growth.

Align Technology’s Q4 2025 earnings beat expectations, driving a 10 % share rally as the company’s $1.63 billion revenue, 30 % profit growth, and strong cash position fuel future growth plans for Invisalign and digital dentistry.